Annals of Allergy, Asthma & Immunology
annalsacaai.bsky.social
Annals of Allergy, Asthma & Immunology
@annalsacaai.bsky.social
Annals of Allergy, Asthma & Immunology is a scholarly medical journal published monthly by the American College of Allergy, Asthma & Immunology. The publication is an objective evidence-based forum for the allergy/immunology specialist to keep up to date.
We are grateful for our readers and authors, reviewers and editors. We are grateful for more than 80 years of publication, as we document our experience, discoveries, our growth in allergy, asthma and immunology. Happy Thanksgiving from Annals!
November 27, 2025 at 5:05 PM
Reposted by Annals of Allergy, Asthma & Immunology
The December issue of Annals of Allergy, Asthma & Immunology is here -- dedicated to Food Protein Induced Enterocolitis Syndrome (FPIES). Read and learn more at www.annallergy.org/current And oh, what a great holiday cover image (see below)! @annalsacaai.bsky.social #MedSky #allergy #immunology
November 24, 2025 at 1:18 PM
Reposted by Annals of Allergy, Asthma & Immunology
A woman with indolent #SystemicMastocytosis presented with #Anaphylaxis following consumption of ackee fruit. Case report in @annalsacaai.bsky.social

Read here: https://bit.ly/4oguPOW

#RareDisease #MedSky #Immunology
Postprandial Illness May Mask Systemic Mastocytosis: A Case Report
An unusual case has been reported of a woman with indolent SM who presented with anaphylaxis following consumption of ackee fruit.
bit.ly
November 25, 2025 at 8:06 PM
Multiple factors can contribute to the increase in infections in AD. Skin barrier defects, immune dysregulation, and skin flora dysbiosis all contribute to the increased risk of infections in AD. Learn more and earn CME! https://loom.ly/D4Y1-rs
November 25, 2025 at 3:06 PM
There is a lack of diversity and representation of historically marginalized groups in current clinical research. The primary objective for this study was to evaluate recruitment and retention strategies for patients historically marginalized in asthma clinical trials. https://loom.ly/sVcJ-vM

November 20, 2025 at 3:04 PM
One of the first-line options for long term prophylaxis in HAE patients is lanadelumab, a fully human monoclonal antibody inhibiting plasma kallikrein. The authors report findings from 2 prospective, noninterventional, multicenter phase 4 studies. Learn more: https://loom.ly/gMx757w
November 18, 2025 at 8:10 PM
Ready to submit an article? Share your expertise and submit it here: https://loom.ly/uBd7yU4
Editorial Manager®
Full-Function Web-Enabled Manuscript Submission and Tracking System for Peer Review
www.editorialmanager.com
November 13, 2025 at 3:05 PM
This review discusses drug hypersensitivity reactions in mastocytosis, focusing on the most frequent drug triggers and their management. A history-driven, evidence-based approach allows most patients to be treated effectively without unnecessary drug avoidance. https://loom.ly/nlkd5RY
November 11, 2025 at 3:06 PM
Chronic rhinosinusitis (CRS) is a common condition evaluated by the allergist-immunologist. Here are 10 things you should know about this common and important condition. https://loom.ly/JT_dPHQ
November 6, 2025 at 3:06 PM
Several new agents have received Food and Drug Administration approval, expanding therapeutic options for patients. These innovations represent a shift toward personalized atopic dermatitis management. Learn more: https://loom.ly/hszCE8g
November 4, 2025 at 3:05 PM
Do you want to write an article for Annals? Here are our guidelines: www.annallergy.org/content/auth...
Information for Authors: Annals of Allergy, Asthma & Immunology
www.annallergy.org
October 30, 2025 at 2:20 PM
Earn CME credit with Annals' CME online exams! Read an article in Annals, then take an exam for CME credit! Learn more: https://loom.ly/h7upvqk
Earn CME with Annals
Annals of Allergy, Asthma & Immunology offers the opportunity to earn CME through some of its articles. Learn more.
www.annallergy.org
October 23, 2025 at 2:05 PM
Did you know Annals features collections of articles based on topic? Asthma, Clinical Practice, Drug Allergy, Immunodeficiency, Rhinosinusitis, and more! Access them in the Collections area about halfway down the Annals homepage: https://loom.ly/qDK5bcY
Collections
Read more about Collections at Annals of Allergy, Asthma & Immunology
www.annallergy.org
October 21, 2025 at 8:30 PM
How do you systematically synthesize the benefits and harms of triple therapy (ICS/LABA/long-acting muscarinic antagonists) compared with dual therapy (ICS/LABA) for asthma management across key subpopulations? Find out here: https://loom.ly/C3UpA6E
Triple therapy vs dual inhaler therapy for moderate-to-severe asthma
An updated systematic review and meta-analysis
www.annallergy.org
October 16, 2025 at 2:05 PM
Two respiratory viruses associated with most recurrent wheeze and asthma development are respiratory syncytial virus (RSV) and rhinovirus (RV). This review evaluates the roles these 2 viruses play in the development of wheeze and asthma. https://loom.ly/hDm2aaI
The usual suspects
Respiratory syncytial virus and rhinovirus drive asthma development and exacerbation
www.annallergy.org
October 14, 2025 at 2:05 PM
Reposted by Annals of Allergy, Asthma & Immunology
Come to this years American College of Allergy, Asthma & Immunology meeting - it is going to be great! I'll be there presenting the best from Annals from the last year. Hope to see you in Orlando! (register at annualmeeting.acaai.org/2025 )
@annalsacaai.bsky.social #ACAAI25
October 8, 2025 at 3:47 PM
Who's this year's winner of the "Pathy" award? (wink, wink) Who was nominated? Who won? Find out in Marginal Zone, only in Annals of Allergy, Asthma & Immunology. https://loom.ly/vx0R1C8
“And the Pathy goes to…”
Erin L. Reigh, MD, MS
www.annallergy.org
October 9, 2025 at 2:04 PM
Asthma disproportionately affects non–English-speaking populations, with language barriers contributing to worse health outcomes, including increased emergency department visits and hospitalizations. Find out what health systems can do to reduce disparities. https://loom.ly/oUepsUM
Impact of language barriers on pulmonary function and asthma control
Language barriers significantly impact asthma management
www.annallergy.org
October 7, 2025 at 2:05 PM
Student health center or clinic administration of subcutaneous immunotherapy (SCIT) while at college/university is not well studied. This study aimed to clarify SCIT administration on campus both from the Allergist’s and student health center's perspectives. https://loom.ly/7DZZCHM
Subcutaneous immunotherapy administration on college campuses
Two exploratory surveys of Florida allergists and student health
www.annallergy.org
October 2, 2025 at 2:05 PM
This study hoped to better understand the experiences of college students with and without food allergy (FA) to determine ways to improve safety and quality of life for those with FA. Were they successful? Find out: https://loom.ly/LRKese4
Determining avenues for improved food allergy support and safety on college campuses
Food Allergy (FA) is a chronic disease with public health importance affecting an estimated 1 in 13 children and 1 in 10 adults.
www.annallergy.org
September 30, 2025 at 2:05 PM
Childhood asthma is more common in boys; however, its prevalence decreases more significantly in boys than in girls during puberty. Sex differences in urinary mast cell mediators remain unreported despite known sex-specific variations in eicosanoid pathways. https://loom.ly/exA7i_g
Sex differences in urinary mast cell mediators
Implications for diagnosing atopic and mast cell disorders
www.annallergy.org
September 25, 2025 at 2:05 PM
Other viruses beyond respiratory syncytial virus (RSV) and rhinovirus play a significant but underappreciated role in asthma inception and exacerbations. Learn more about these other respiratory bandits and earn CME: https://loom.ly/Dj3KirY
Beyond respiratory syncytial virus and rhinovirus
The other viral respiratory bandits
www.annallergy.org
September 23, 2025 at 2:05 PM
Wonder what your colleagues are reading in Annals? Take a look at the Most Read (Last 30 Days) section of the Annals homepage and find out! www.annallergy.org
Home Page: Annals of Allergy, Asthma & Immunology
www.annallergy.org
September 18, 2025 at 3:06 PM
Peanut has been implicated as the leading or among the leading causes of fatal anaphylactic reactions. Guidance emphasizes the importance of individualizing treatment and the potential for immunotherapy and omalizumab. www.annallergy.org/article/S108...
Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities
There is a high prevalence rate of atopic comorbidities, including atopic dermatitis (AD), asthma, and concomitant food allergy (CFA), in children with peanut allergy.
www.annallergy.org
September 16, 2025 at 2:08 PM
The September 2025 issue of Annals of Allergy, Asthma & Immunology focuses on respiratory viruses and asthma. Read the highlights: college.acaai.org/the-septembe...
The September issue of Annals focuses on respiratory viruses and asthma - ACAAI Member
Do you know what the National Asthma Control Program (NACP) is and why it is important to asthma care in the United States?
college.acaai.org
September 11, 2025 at 4:18 PM